Risk Factors and Deep Learning Model for CI-AKI

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

2000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-06-01

Study Completion Date

2025-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Contrast-associated acute kidney injury (CI-AKI) is a sudden and significant decline in renal function resulting from the use of a contrast agent.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Deep Learning Model and Risk Factors for Tacrolimus-related Acute Kidney Injury

NCT06596798

AKI

ACTIVE_NOT_RECRUITING

Assessment of AI Prediction Models in Prediction of Acute Kidney Injury in Critical Patients

NCT06857188

Acute Kidney Failure Artificial Intelligence (AI)

NOT_YET_RECRUITING

Research on the Risk Warning Model and Prevention Strategies for Acute Kidney Injury Associated With Cyclosporine Based on Explainable Deep Neural Networks and Therapeutic Drug Monitoring

NCT06596811

AKI Therapeutic Drug Monitoring (TDM)

ACTIVE_NOT_RECRUITING

Risk Factors and Machine Learning Model for Diuretics Related Acute Kidney Injury

NCT05527054

Diuretic Toxicity Acute Kidney Injury

ACTIVE_NOT_RECRUITING

Machine Learning Predict Acute Kidney Injury in Patients Following Cardiac Surgery

NCT04966598

Machine Learning Acute Kidney Injury

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Contrast-associated acute kidney injury (CI-AKI) is a sudden and significant decline in renal function resulting from the use of a contrast agent. Despite the frequent use of iodinated contrast agents in medical investigations, predictive models for CI-AKI are scarce. This study aimed to construct and validate interpretable deep learning models for the early risk prediction of acute kidney injury (AKI) associated with iodinated contrast agents.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

AKI - Acute Kidney Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients who received iodinated contrast agents during hospitalization
* age ≥ 18 years
* hospitalization length ≥ 48 hours
* at least two serum creatinine tests during hospitalization

Exclusion Criteria

* patients with stage 4 or 5 chronic kidney disease prior to admission
* patients undergoing hemodialysis, hemofiltration or peritoneal before admission
* a history of nephrectomy or kidney transplantation during hospitalization
* incomplete clinical information
* Serum creatinine always ≤ 40 μmol/L during hospitalization

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes